RhumbLine Advisers’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.56M | Sell |
37,225
-5,324
| -13% | -$362K | ﹤0.01% | 1815 |
|
|
2026
Q1 | $3.19M | Sell |
42,549
-6,151
| -13% | -$504K | ﹤0.01% | 1620 |
|
|
2025
Q4 | $3.8M | Sell |
48,700
-2,457
| -5% | -$199K | ﹤0.01% | 1537 |
|
|
2025
Q3 | $4.35M | Sell |
51,157
-3,731
| -7% | -$299K | ﹤0.01% | 1505 |
|
|
2025
Q2 | $4.29M | Buy |
54,888
+1,632
| +3% | +$120K | ﹤0.01% | 1495 |
|
|
2025
Q1 | $3.85M | Buy |
53,256
+1,794
| +3% | +$151K | ﹤0.01% | 1479 |
|
|
2024
Q4 | $4.57M | Sell |
51,462
-584
| -1% | -$52K | ﹤0.01% | 1468 |
|
|
2024
Q3 | $4.4M | Sell |
52,046
-2,729
| -5% | -$242K | ﹤0.01% | 1493 |
|
|
2024
Q2 | $5.06M | Sell |
54,775
-209
| -0.4% | -$21.1K | ﹤0.01% | 1389 |
|
|
2024
Q1 | $6.21M | Buy |
54,984
+1,125
| +2% | +$112K | 0.01% | 1302 |
|
|
2023
Q4 | $5.02M | Sell |
53,859
-123
| -0.2% | -$10.8K | 0.01% | 1408 |
|
|
2023
Q3 | $4.95M | Sell |
53,982
-1,575
| -3% | -$169K | 0.01% | 1352 |
|
|
2023
Q2 | $6.74M | Buy |
55,557
+2,573
| +5% | +$277K | 0.01% | 1206 |
|
|
2023
Q1 | $5.19M | Buy |
52,984
+6,033
| +13% | +$576K | 0.01% | 1288 |
|
|
2022
Q4 | $3.8M | Buy |
46,951
+91
| +0.2% | +$7.63K | 0.01% | 1437 |
|
|
2022
Q3 | $3.56M | Sell |
46,860
-769
| -2% | -$73.9K | 0.01% | 1431 |
|
|
2022
Q2 | $5.2M | Buy |
47,629
+689
| +1% | +$73.2K | 0.01% | 1221 |
|
|
2022
Q1 | $4.67M | Buy |
46,940
+14,547
| +45% | +$1.39M | 0.01% | 1356 |
|
|
2021
Q4 | $3.1M | Buy |
32,393
+169
| +0.5% | +$16.9K | ﹤0.01% | 1635 |
|
|
2021
Q3 | $3.56M | Sell |
32,224
-4,741
| -13% | -$540K | ﹤0.01% | 1559 |
|
|
2021
Q2 | $4.28M | Sell |
36,965
-1,521
| -4% | -$175K | 0.01% | 1504 |
|
|
2021
Q1 | $4.01M | Sell |
38,486
-17,507
| -31% | -$2.18M | 0.01% | 1534 |
|
|
2020
Q4 | $6.73M | Buy |
55,993
+1,282
| +2% | +$129K | 0.01% | 1179 |
|
|
2020
Q3 | $4.75M | Sell |
54,711
-23,881
| -30% | -$2.05M | 0.01% | 1202 |
|
|
2020
Q2 | $6.37M | Sell |
78,592
-3,037
| -4% | -$222K | 0.01% | 1054 |
|
|
2020
Q1 | $5.63M | Buy |
81,629
+19,231
| +31% | +$2.03M | 0.01% | 953 |
|
|
2019
Q4 | $7.13M | Buy |
62,398
+2,328
| +4% | +$290K | 0.01% | 1045 |
|
|
2019
Q3 | $7.84M | Buy |
60,070
+7,033
| +13% | +$916K | 0.01% | 918 |
|
|
2019
Q2 | $6.5M | Buy |
53,037
+4,517
| +9% | +$519K | 0.01% | 1048 |
|
|
2019
Q1 | $5.1M | Sell |
48,520
-5,525
| -10% | -$594K | 0.01% | 1167 |
|
|
2018
Q4 | $5.53M | Buy |
54,045
+5,883
| +12% | +$653K | 0.01% | 1037 |
|
|
2018
Q3 | $5.71M | Buy |
48,162
+4,077
| +9% | +$461K | 0.01% | 1025 |
|
|
2018
Q2 | $4.23M | Buy |
44,085
+1,038
| +2% | +$96.3K | 0.01% | 1218 |
|
|
2018
Q1 | $3.5M | Buy |
43,047
+487
| +1% | +$37.7K | 0.01% | 1278 |
|
|
2017
Q4 | $3.07M | Buy |
42,560
+1,831
| +4% | +$125K | 0.01% | 1365 |
|
|
2017
Q3 | $2.5M | Buy |
40,729
+5,570
| +16% | +$339K | 0.01% | 1469 |
|
|
2017
Q2 | $2.12M | Sell |
35,159
-380
| -1% | -$24.3K | ﹤0.01% | 1542 |
|
|
2017
Q1 | $2.32M | Buy |
35,539
+18,975
| +115% | +$1.34M | 0.01% | 1465 |
|
|
2016
Q4 | $1.16M | Buy |
16,564
+486
| +3% | +$30.9K | ﹤0.01% | 1780 |
|
|
2016
Q3 | $1.01M | Buy |
16,078
+1,095
| +7% | +$67.5K | ﹤0.01% | 1795 |
|
|
2016
Q2 | $902K | Buy |
14,983
+238
| +2% | +$13K | ﹤0.01% | 1848 |
|
|
2016
Q1 | $733K | Buy |
14,745
+340
| +2% | +$16.9K | ﹤0.01% | 1984 |
|
|
2015
Q4 | $773K | Buy |
14,405
+2,825
| +24% | +$142K | ﹤0.01% | 1972 |
|
|
2015
Q3 | $520K | Buy |
11,580
+469
| +4% | +$23.4K | ﹤0.01% | 2200 |
|
|
2015
Q2 | $608K | Sell |
11,111
-1,115
| -9% | -$55.2K | ﹤0.01% | 2207 |
|
|
2015
Q1 | $581K | Buy |
12,226
+2,175
| +22% | +$92.5K | ﹤0.01% | 2207 |
|
|
2014
Q4 | $422K | Buy |
10,051
+300
| +3% | +$11.8K | ﹤0.01% | 2374 |
|
|
2014
Q3 | $345K | Buy |
9,751
+50
| +0.5% | +$1.77K | ﹤0.01% | 2443 |
|
|
2014
Q2 | $332K | Sell |
9,701
-322
| -3% | -$10.4K | ﹤0.01% | 2540 |
|
|
2014
Q1 | $346K | Sell |
10,023
-580
| -5% | -$19.2K | ﹤0.01% | 2443 |
|
|
2013
Q4 | $374K | Sell |
10,603
-500
| -5% | -$16.4K | ﹤0.01% | 2433 |
|
|
2013
Q3 | $345K | Sell |
11,103
-99
| -0.9% | -$2.92K | ﹤0.01% | 2438 |
|
|
2013
Q2 | $310K | Buy |
+11,202
| New | +$296K | ﹤0.01% | 2614 |
|
Other funds holding USPH
BG
CCM
SAM
RhumbLine Advisers's USPH Position: Q2 2026 in Review
RhumbLine Advisers reduced its US Physical Therapy (USPH) stake by 13% in Q2 2026, selling an estimated $362K and leaving 37,225 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1815.
RhumbLine Advisers first reported a position in USPH in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.84M in Q3 2019. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.
- RhumbLine Advisers held 37,225 shares of US Physical Therapy worth $2.56M as of Q2 2026.
- RhumbLine Advisers sold 5,324 US Physical Therapy shares in Q2 2026, an estimated $362K.
- US Physical Therapy made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1815 holding.
- RhumbLine Advisers first reported a position in US Physical Therapy in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's US Physical Therapy position peaked at $7.84M in Q3 2019.
- 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.